Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort - Dressel, Alexander; Grammer, Tanja B.; März, Winfried (Vascular pharmacology, 2019)
Gesehen am 06.11.2019